ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 -0.05 (-100.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Total Non-Current Liabilities (2022 - 2026)

Updated

ZyVersa Therapeutics' Total Non-Current Liabilities came in at $14.74 million for Q1 2026.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Going back to Q1 2022, ZyVersa Therapeutics' Total Non-Current Liabilities data covers 7 quarters.

  • The Q1 2026 figure represents the highest quarterly Total Non-Current Liabilities since Q1 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 14.74 Mn
Sep 30, 2023 13.15 Mn
Jun 30, 2023 11.93 Mn
Mar 31, 2023 17.86 Mn
Dec 31, 2022 18.84 Mn
Jun 30, 2022 79.22 Mn
Mar 31, 2022 79.28 Mn
API Access

ZyVersa Therapeutics, Inc. Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZVSA&period=max&api_key=YOUR_API_KEY